BeStock  
Markets › Compare › NVCT vs AURA

NVCT vs AURA

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
NVCT · Nuvectis Pharma$19.39 ▼ 2.27%
AURA · Aura Biosciences$6.87 ▼ 1.58%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

67175283391499Nov 24, '25May 26, '26Nov 20, '26
  • NVCT +223.7%
  • AURA +24.9%

Head to head

MetricNVCTAURA
Price$19.39$6.87
Change today▼ 2.27%▼ 1.58%
Market cap$666.80M$714.99M
Return, 3 months-18.8%-13.0%
Return, year to date+156.8%+26.1%
Return, 1 year+218.9%+26.3%
P/E (TTM)––
P/B5.32.5
P/E percentile vs own 5y22nd46th
Dividend yield––
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)-303.0%-22.7%
Gross margin––
Operating margin––
Net margin––
Return on equity-67.0%-61.7%
Analyst target vs. price+77.9%+162.0%
Analyst buy share100%100%
RSI (14)4751
30-day volatility78.4%64.9%
Max drawdown, 1 year-37.7%-32.6%
Trend readLeaning bearishStrong uptrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • AURA is the largest of the group by market value.
  • NVCT has returned the most over the past year.
  • AURA has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top